Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | SHH | Q15465 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15616246 | 1.00 | CA1 (0.42) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15616247 | 1.00 | CA1 (0.42) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15616240 | 1.00 | CA1 (0.42) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15616242 | 1.00 | CA1 (0.42) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15616207 | 1.00 | CA1 (0.42) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15616241 | 0.83 | CYP2C19 (0.41) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15616245 | 0.83 | CYP2C19 (0.41) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15577084 | 0.83 | CYP2C19 (0.41) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL30743830 | 0.83 | CYP2C19 (0.41) | CA1CA9ATMCYP2C19CYP2D6 | |
| SCHEMBL15577083 | 0.83 | CYP2C19 (0.41) | CA1CA9ATMCYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5831101-A | 14-methyl-hexadecenolide and 14-methyl-hexadecanolide | QUEST INTERNATIONAL B.V. (NL) | 1998-11-03 | — | — | US | claimed |
| EP-0841333-A1 | 14-Methyl-hexadecenolide and 14-methyl-hexadecanolide | QUEST INTERNATIONAL B.V. (NL) | 1998-05-13 | — | — | EP | claimed |
| JP-10204078-A | — | — | None | — | — | JP | disclosed |
| EP-2781515-B1 | 13-Methyl-9-cyclopentadecen-15-olide | KAO CORP (JP) | 2016-02-24 | — | — | EP | disclosed |
| EP-1741706-B1 | 11-METHYL-13-TRIDECANOLIDE, 12-METHYL-14-TETRADECANOLIDE AND 13-METHYL-15-PENTADECANOLIDE, PERFUME COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR THE PRODUCTION OF THE COMPOUNDS | SODA AROMATIC COMPANY LTD (JP) | 2014-01-22 | — | — | EP | disclosed |
| US-7569535-B2 | 11-methyl-13-tridecanolide, 12-methyl-14-tetradecanolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for production of compounds including the same | SODA AROMATIC CO., LTD. (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20080020963-A1 | 11-methyl-13-tridecanolide (2-oxo-12-methyl-1-oxacyclotetradecane); perfumes with distinctive fragrance characteristics; musk excellent in persistency but also fragrance characteristics like nitro musks | SODA AROMATIC CO., LTD., A CORPORATION OF JAPAN | 2008-01-24 | — | — | US | disclosed |
| EP-1741706-A1 | 11-METHYL-13-TRIDECANOLIDE, 12-METHYL-14-TETRADECA- NOLIDE AND 13-METHYL-15-PENTADECANOLIDE, PERFUME COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR THE PRODUCTION OF COMPOUNDS INCLUDING THE SAME | SODA AROMATIC COMPANY, LIMITED (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-5831101-A | 14-methyl-hexadecenolide and 14-methyl-hexadecanolide | QUEST INTERNATIONAL B.V. (NL) | 1998-11-03 | — | — | US | disclosed |
| US-5831101-A | 14-methyl-hexadecenolide and 14-methyl-hexadecanolide | QUEST INTERNATIONAL B.V. (NL) | 1998-11-03 | — | — | US | disclosed |
| JP-H10204078-A | 14-METHYL-HEXADECENOLIDE AND 14-METHYL-HEXADECANOLIDE | QUEST INTERNATL BV | 1998-08-04 | — | — | JP | disclosed |
| EP-0841333-A1 | 14-Methyl-hexadecenolide and 14-methyl-hexadecanolide | QUEST INTERNATIONAL B.V. (NL) | 1998-05-13 | — | — | EP | disclosed |
| EP-0841333-A1 | 14-Methyl-hexadecenolide and 14-methyl-hexadecanolide | QUEST INTERNATIONAL B.V. (NL) | 1998-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080020963-A1 | 11-methyl-13-tridecanolide (2-oxo-12-methyl-1-oxacyclotetradecane); perfumes with distinctive fragrance characteristics; musk excellent in persistency but also fragrance characteristics like nitro musks | METTL14, TNK1, MDK | CA1 3749/4885CA9 2632/4885ATM 2498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.